Showing 9,841 - 9,860 results of 30,491 for search '(( 2 step decrease ) OR ( 50 ((((a decrease) OR (nn decrease))) OR (mean decrease)) ))', query time: 0.72s Refine Results
  1. 9841

    Mecp2 occupancy at the <i>Avp</i> enhancer coupled with repressive chromatin marks and repressor complexes. by Chris Murgatroyd (373352)

    Published 2014
    “…B, PVN tissues from Mecp2 null male (-/y) mice showed increased H3Ac and decreased H3K9me2 chromatin marks at the <i>Avp</i> enhancer compatible with a repressor function of Mecp2. …”
  2. 9842

    Image_5_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  3. 9843

    Table_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.DOCX by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  4. 9844

    Image_4_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  5. 9845

    Image_3_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  6. 9846

    Image_2_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  7. 9847

    Image_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  8. 9848
  9. 9849

    Cryosections (8 µm) of intercostal muscle from a normal dog, a Labrador Retriever with CMS (end-plate AChE deficiency), and a Jack Russell Terrier with CMS due to AChR deficiency (... by Caitlin J. Rinz (622800)

    Published 2014
    “…In the CMS Jack Russell Terrier esterase staining was present; however, staining for AChR was markedly decreased or absent, consistent with a markedly decreased AChR content. …”
  10. 9850
  11. 9851

    <i>In-situ</i> recording of ionic currents in projection neurons and Kenyon cells in the olfactory pathway of the honeybee - Fig 2 by Jan Kropf (178122)

    Published 2018
    “…C: I-V plots of the mean currents of the two neuronal types. Note the persistent K<sup>+</sup> current decreasing above 30 mV hinting Ca<sup>2+</sup> dependent K<sup>+</sup> currents in the I(K<sup>+</sup>p) in KCs.…”
  12. 9852

    Reduction of cell viability via FINs is (partially) reversed by deferoxamine mesylate and ferrostatin-1. by Dino Bekric (16475280)

    Published 2024
    “…(A) Cell viability data is shown as mean values +/- SEM of n = 3 biological replicates of CCC-5 cells with FINs (light grey) and FINS + cell death inhibitors (dark grey) treatment for 24 h. …”
  13. 9853
  14. 9854

    Demographic data. by Narisa Rattanalert (21445983)

    Published 2025
    “…Mean rubric scores indicative of LIO-ROP skills significantly improved from 2.94 to 3.59 out of 4 (P < 0.001), and the time required for the laser procedure decreased from 17.19 to 15.14 minutes in pre- and post-LIO-ROP practice, respectively. …”
  15. 9855

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  16. 9856

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  17. 9857

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  18. 9858

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  19. 9859

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  20. 9860